Migraine

Epidemiology, Burden, and Comorbidity

Rebecca C. Burch, Dawn C. Buse, Richard B. Lipton

Research output: Contribution to journalReview article

Abstract

Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.

Original languageEnglish (US)
JournalNeurologic Clinics
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Migraine Disorders
Comorbidity
Epidemiology
Psychiatry
Health Resources
Social Class
Population
Headache
Cardiovascular Diseases
Quality of Life
Delivery of Health Care
Costs and Cost Analysis

Keywords

  • Chronic migraine (CM)
  • Comorbidity
  • Headache-related disability
  • Incidence
  • Migraine
  • Prevalence
  • Progression
  • Risk factors

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Migraine : Epidemiology, Burden, and Comorbidity. / Burch, Rebecca C.; Buse, Dawn C.; Lipton, Richard B.

In: Neurologic Clinics, 01.01.2019.

Research output: Contribution to journalReview article

@article{e8123f8f74dd44d2bda6694215a99795,
title = "Migraine: Epidemiology, Burden, and Comorbidity",
abstract = "Migraine affects an estimated 12{\%} of the population. Global estimates are higher. Chronic migraine (CM) affects 1{\%} to 2{\%} of the global population. Approximately 2.5{\%} of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.",
keywords = "Chronic migraine (CM), Comorbidity, Headache-related disability, Incidence, Migraine, Prevalence, Progression, Risk factors",
author = "Burch, {Rebecca C.} and Buse, {Dawn C.} and Lipton, {Richard B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ncl.2019.06.001",
language = "English (US)",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Migraine

T2 - Epidemiology, Burden, and Comorbidity

AU - Burch, Rebecca C.

AU - Buse, Dawn C.

AU - Lipton, Richard B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.

AB - Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.

KW - Chronic migraine (CM)

KW - Comorbidity

KW - Headache-related disability

KW - Incidence

KW - Migraine

KW - Prevalence

KW - Progression

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85071289596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071289596&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2019.06.001

DO - 10.1016/j.ncl.2019.06.001

M3 - Review article

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

ER -